Analyze Diet
Equine veterinary journal2015; 48(6); 710-713; doi: 10.1111/evj.12502

Duration of tetanus immunoglobulin G titres following basic immunisation of horses.

Abstract: Recommendations for prophylactic vaccination against tetanus in horses vary greatly between countries and have scarce scientific support in the peer-reviewed literature. In human medicine, recommended booster vaccination intervals are also very variable, but are considerably longer than for horses. More information is needed about the duration of immunity induced by modern vaccines. Objective: To investigate if the duration of antibody titres previously determined to be protective against tetanus differ from what is indicated by recommended vaccination intervals for horses. Methods: Prospective seroconversion study. Methods: Thirty-four horses were enrolled for basic immunisation with an ISCOM Matrix-combination vaccine (Equilis Prequenza Te). Horses received the first vaccination at age 5-11 months, and the second dose 4 weeks later. A third vaccine dose was given 15-17 months after the second dose. Serum tetanus antibody titres were analysed by toxin-binding enzyme-linked immunosorbent assay 2 weeks as well as 14-16 months after the second dose. After the third vaccine dose, titres were checked once yearly for 3 years. Results were described by age and level of antibody titre at first sampling. Results: Two weeks after the second dose, all horses (34/34) had antibody levels that exceeded the limit of detection, 0.04 iu/ml. After 16 months the levels were above 0.04 iu/ml in 28/33 horses, the remaining 5 horses potentially had suboptimal protection against tetanus. After the third vaccine dose antibody levels remained above 0.04 iu/ml in 25/26 horses for 1 year, 16/16 horses for 2 years, and 8/8 horses for 3 years. Conclusions: Horses that undergo basic immunisation with 3 doses of vaccine after age 5 months are likely to have serum antibody titres consistent with protection against tetanus for more than 3 years. Current guidelines for tetanus prophylaxis should be revised.
Publication Date: 2015-09-20 PubMed ID: 26284567DOI: 10.1111/evj.12502Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses a study undertaken to examine the duration of protective tetanus antibodies in horses following basic immunisation. The findings suggest that horses older than 5 months, after receiving three doses of a particular vaccine, are likely to have sufficient antibody levels for tetanus protection for more than three years. This calls for a revision in current prophylaxis guidelines for tetanus in horses.

Objective of the Research

  • The research aims to understand if the duration of antibody titres, especially those known to provide protection against tetanus, differ from what is indicated by the recommended vaccination intervals in horses. The motive behind this is to provide a more accurate vaccination guideline for horses, based on scientific data.

Methodology

  • The researchers conducted a prospective seroconversion study in which 34 horses were used.
  • An ISCOM Matrix-combination vaccine (Equilis Prequenza Te) was administered to the horses for basic immunisation.
  • The horses received the first vaccine when they were between 5 to 11 months old, and the second dose was given 4 weeks later.
  • The third vaccine dose was administered 15 to 17 months after the second dose.
  • Tetanus antibody titres in the serum were analysed by employing the enzyme-linked immunosorbent assay (ELISA) technique two weeks after the second dose, again after 14-16 months of the second dose and then annually for three years following the third vaccine dose.

Results

  • The results indicate that after the second dose of vaccine, all the horses had antibody levels that were detectable and have protective potential against tetanus.
  • However, after about 16 months, the protective antibody levels dropped in some horses, suggesting these horses might have reduced immunity against tetanus.
  • The yearly checks after the third vaccine dose showed that a significant number of horses were still capable of producing protective antibodies three years after the initial basic immunisation.

Conclusions

  • The results demonstrated that horses aged above 5 months, upon receiving three vaccine doses, have a high likelihood of maintaining protective tetanus antibody titres for more than three years.
  • Based on this finding, the researchers suggest revision of existing guidelines for prophylactic tetanus vaccination in horses. They recommend a longer duration between tetanus immunisation boosters may be considered to provide effective protection against the disease.

Cite This Article

APA
Kendall A, Anagrius K, Gånheim A, Rosanowski SM, Bergström K. (2015). Duration of tetanus immunoglobulin G titres following basic immunisation of horses. Equine Vet J, 48(6), 710-713. https://doi.org/10.1111/evj.12502

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 48
Issue: 6
Pages: 710-713

Researcher Affiliations

Kendall, A
  • Mälaren Equine Clinic, Sigtuna, Sweden. annak@hastklinik.se.
Anagrius, K
  • Swedish University of Agricultural Sciences, Uppsala, Sweden.
Gånheim, A
  • The Equine Clinic Bollerup, Tomelilla, Sweden.
Rosanowski, S M
  • Department of Production and Population Health, The Royal Veterinary College, University of London, UK.
Bergström, K
  • National Veterinary Institute, Uppsala, Sweden.

MeSH Terms

  • Animals
  • Antibodies, Bacterial / blood
  • Horse Diseases / prevention & control
  • Horses
  • Immunoglobulin G / blood
  • Tetanus / blood
  • Tetanus / immunology
  • Tetanus / prevention & control
  • Tetanus Toxoid / immunology

Citations

This article has been cited 4 times.
  1. Kinoshita Y, Yamanaka T, Kodaira K, Niwa H, Uchida-Fujii E, Ueno T. Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year.. J Vet Med Sci 2023 Jul 17;85(7):751-754.
    doi: 10.1292/jvms.23-0158pubmed: 37258221google scholar: lookup
  2. de Melo UP, Ferreira C. Clinical findings and response to treatment of 17 cases of tetanus in horses (2012-2021).. Braz J Vet Med 2022;44:e005321.
    doi: 10.29374/2527-2179.bjvm005321pubmed: 35749097google scholar: lookup
  3. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
    doi: 10.3390/vaccines10030398pubmed: 35335029google scholar: lookup
  4. Paillot R, Garrett D, Lopez-Alvarez MR, Birand I, Montesso F, Horspool L. The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain.. Vaccines (Basel) 2018 Jul 2;6(3).
    doi: 10.3390/vaccines6030038pubmed: 30004410google scholar: lookup